Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, 05 1997, 1010-1016, Vol 41, No. 5
J Fung-Tomc, K Bush, B Minassian, B Kolek, R Flamm, E Gradelski and D Bonner
The in vitro activities of a new catechol-containing monobactam, BMS-
180680 (SQ 84,100), were compared to those of aztreonam, ceftazidime,
imipenem, piperacillin-tazobactam, ciprofloxacin, amikacin, and
trimethoprim-sulfamethoxazole. BMS-180680 was often the most active
compound against many species of the family Enterobacteriaceae, with MICs
at which 90% of the isolates were inhibited (MIC90s) of < or = 0.5
microg/ml for Escherichia coli, Klebsiella spp., Citrobacter diversus,
Enterobacter aerogenes, Serratia marcescens, Proteus spp., and Providencia
spp. BMS-180680 had moderate activities (MIC90s of 2 to 8 microg/ml)
against Citrobacter freundii, Morganella morganii, Shigella spp., and
non-E. aerogenes Enterobacter spp. BMS-180680 was the only antibiotic
evaluated that was active against >90% of the Pseudomonas aeruginosa
(MIC90, 0.25 microg/ml), Burkholderia cepacia, and Stenotrophomonas
maltophilia (MIC90s, 1 microg/ml) strains tested. BMS- 180680 was inactive
against most strains of Pseudomonas fluorescens, Pseudomonas stutzeri,
Pseudomonas diminuta, and Burkholderia pickettii. BMS-180680 was moderately
active (MIC90s of 4 to 8 microg/ml) against Alcaligenes spp. and
Acinetobacter lwoffii and less active (MIC90, 16 microg/ml) against
Acinetobacter calcoaceticus-Acinetobacter baumanii complex. BMS-180680
lacked activity against gram-positive bacteria and anaerobic bacteria. Both
tonB and cir fiu double mutants of E. coli had greatly decreased
susceptibility to BMS-180680. Of the TEM, PSE, and chromosomal-encoded
beta-lactamases tested, only the K1 enzyme hydrolyzed BMS-180680 to any
measurable extent. Like aztreonam, BMS- 180680 bound preferentially to
penicillin-binding protein 3. The MICs of BMS-180680 were not influenced by
the presence of hematin or 5% sheep blood in the test medium or with
incubation in an atmosphere containing 5% CO2. BMS-180680 MICs obtained
under strict anaerobic conditions were significantly higher than those
obtained in ambient air.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Antibacterial activity of BMS-180680, a new catechol-containing monobactam
Department of Microbiology, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492, USA. joan fung- tomc@ccmail.bms.com
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»